Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523235 · ClinicalTrials.gov registry record · Phase 4
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
A Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT02523235 is a Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain that has completed, run by University of California, San Diego. The registered enrollment target is 117 participants, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02523235, a Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently, continuous adductor canal and popliteal-sciatic nerve blocks are used commonly for lower extremity post-operative pain control, specifically for total knee arthroplasty and foot/ankle surgery, respectively. A perineural catheter used to infuse local anesthetic for postoperative analgesia may be placed at various locations along the target nerves. Investigations of single-injection peripheral nerve blocks suggest that the onset of the block might be faster with one location over the other; but, the success rates are equivalent. However, remaining unknown is whether there is an optimal location to place a perineural catheter as part of a continuous peripheral nerve block.
Conditions Studied
Interventions
- DRUG ropivacaine 0.2%
Study Locations (1)
California
- University California San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02523235
The ClinicalTrials.gov registry entry for NCT02523235 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (60% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which ropivacaine 0.2% is the first listed.
NCT02523235 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02523235 about?
NCT02523235 is a clinical study titled "Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks". Currently, continuous adductor canal and popliteal-sciatic nerve blocks are used commonly for lower extremity post-operative pain control, specifically for total knee arthroplasty and foot/ankle surgery, respectively. A perineural catheter used to infuse local anesthetic for postoperative analgesia ...
What is the current status of trial NCT02523235?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 117 participants. The study started on 2015-08. Estimated completion is 2018-03.
What conditions does trial NCT02523235 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty, Post-surgical Pain, Foot/Ankle Surgery, Catheterization for Postop Analgesia.
What interventions are being tested in trial NCT02523235?
The interventions under investigation include: ropivacaine 0.2% (DRUG).
Who is sponsoring clinical trial NCT02523235?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523235 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty
RECRUITING · Phase 4
-
Medrol Dosepak for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
RECRUITING · Phase 4
-
A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty
COMPLETED · Phase 4
-
Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?
COMPLETED · Phase 4
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.